The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity
2003 · Journal of Translational Medicine · 115 citations
https://doi.org/10.1186/1479-5876-1-14
K
Kimberly Shafer-Weaver
Science Applications International Corporation (United States)(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
1.8K
Citations
19
h-index
21
i10-index
Kimberly Shafer-Weaver is an academic researcher from Science Applications International Corporation (United States). The author has contributed to research in topics: Immunotherapy and Immune Responses & CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 19, co-authored 36 publications.
Papers by this author
worksHER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors
2011 · Clinical Cancer Research · 50 citations
https://doi.org/10.1158/1078-0432.ccr-10-2887
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets
2004 · Journal of Translational Medicine · 40 citations
https://doi.org/10.1186/1479-5876-2-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat